266 related articles for article (PubMed ID: 15580324)
21. Immunologic sensitization in recipients of left ventricular assist devices.
John R; Lietz K; Schuster M; Naka Y; Rao V; Mancini DM; Rose EA; Smith CR; Oz MC; Edwards NM; Itescu S
J Thorac Cardiovasc Surg; 2003 Mar; 125(3):578-91. PubMed ID: 12658200
[TBL] [Abstract][Full Text] [Related]
22. Pneumatic pulsatile ventricular assist device as a bridge to heart transplantation in pediatric patients.
Amodeo A; Brancaccio G; Michielon G; Filippelli S; Ricci Z; Morelli S; Gagliardi MG; Iacobelli R; Pongiglione G; Di Donato RM
Artif Organs; 2010 Nov; 34(11):1017-22. PubMed ID: 21092045
[TBL] [Abstract][Full Text] [Related]
23. Use of the MicroMed DeBakey VAD for the treatment of end-stage heart failure.
DeBakey ME; Teitel ER
Expert Rev Med Devices; 2005 Mar; 2(2):137-40. PubMed ID: 16293049
[TBL] [Abstract][Full Text] [Related]
24. Extracorporeal membrane oxygenation and Thoratec pneumatic ventricular assist devices as double bridge to heart transplantation.
Chou NK; Luo JM; Chi NH; Wu IH; Huang SC; Chen YS; Yu HY; Tsao CI; Ko WJ; Chu SH; Wang SS
Transplant Proc; 2012 May; 44(4):878-80. PubMed ID: 22564572
[TBL] [Abstract][Full Text] [Related]
25. Bridging to transplant with the HeartMate left ventricular assist device: The Columbia Presbyterian 12-year experience.
Morgan JA; John R; Rao V; Weinberg AD; Lee BJ; Mazzeo PA; Flannery MR; Chen JM; Oz MC; Naka Y
J Thorac Cardiovasc Surg; 2004 May; 127(5):1309-16. PubMed ID: 15115987
[TBL] [Abstract][Full Text] [Related]
26. Left ventricular assist device-related infection: treatment and outcome.
Simon D; Fischer S; Grossman A; Downer C; Hota B; Heroux A; Trenholme G
Clin Infect Dis; 2005 Apr; 40(8):1108-15. PubMed ID: 15791509
[TBL] [Abstract][Full Text] [Related]
27. Use of a continuous-flow device in patients awaiting heart transplantation.
Miller LW; Pagani FD; Russell SD; John R; Boyle AJ; Aaronson KD; Conte JV; Naka Y; Mancini D; Delgado RM; MacGillivray TE; Farrar DJ; Frazier OH;
N Engl J Med; 2007 Aug; 357(9):885-96. PubMed ID: 17761592
[TBL] [Abstract][Full Text] [Related]
28. Impact of abdominal complications on outcome after mechanical circulatory support.
Bhama JK; Rayappa S; Zaldonis D; Adusumilli PS; Bansal A; Genovese EA; Teuteberg JJ; Toyoda Y; Siegenthaler MP; Bermudez CA; McCurry KR; Kormos RL
Ann Thorac Surg; 2010 Feb; 89(2):522-8; discussion 528-9. PubMed ID: 20103336
[TBL] [Abstract][Full Text] [Related]
29. Clinical outcomes associated with chronic antimicrobial suppression therapy in patients with continuous-flow left ventricular assist devices.
Jennings DL; Chopra A; Chambers R; Morgan JA
Artif Organs; 2014 Oct; 38(10):875-9. PubMed ID: 24571683
[TBL] [Abstract][Full Text] [Related]
30. The pharmacotherapy of the HeartMate II, a continuous flow left ventricular assist device, in patients with advanced heart failure: integration of disease, device, and drug.
Jennings DL; Chambers RM; Schillig JM
Ann Pharmacother; 2010 Oct; 44(10):1647-50. PubMed ID: 20841512
[TBL] [Abstract][Full Text] [Related]
31. Outcomes of left ventricular assist device implantation as destination therapy in the post-REMATCH era: implications for patient selection.
Lietz K; Long JW; Kfoury AG; Slaughter MS; Silver MA; Milano CA; Rogers JG; Naka Y; Mancini D; Miller LW
Circulation; 2007 Jul; 116(5):497-505. PubMed ID: 17638928
[TBL] [Abstract][Full Text] [Related]
32. Long-term outcome of high-urgency heart transplant patients with and without temporary ventricular assist device support.
Castel MA; Cartañá R; Cardona M; Pereda D; Hernández M; Sandoval E; Castella M; Pérez-Villa F
Transplant Proc; 2012 Nov; 44(9):2642-4. PubMed ID: 23146481
[TBL] [Abstract][Full Text] [Related]
33. Bridge to transplant experience: factors influencing survival to and after cardiac transplant.
Smedira NG; Hoercher KJ; Yoon DY; Rajeswaran J; Klingman L; Starling RC; Blackstone EH
J Thorac Cardiovasc Surg; 2010 May; 139(5):1295-305, 1305.e1-4. PubMed ID: 20412961
[TBL] [Abstract][Full Text] [Related]
34. [Heart transplantation--indications and results].
Loebe M; Hetzer R; Schüler S; Hummel M; Friedel N; Weng Y; Schiessler A
Zentralbl Chir; 1992; 117(12):681-8. PubMed ID: 1285476
[TBL] [Abstract][Full Text] [Related]
35. State of the art: implantable ventricular assist devices.
Lahpor JR
Curr Opin Organ Transplant; 2009 Oct; 14(5):554-9. PubMed ID: 19667990
[TBL] [Abstract][Full Text] [Related]
36. Invited commentary.
Esmore DS
Ann Thorac Surg; 2010 Oct; 90(4):1277. PubMed ID: 20868827
[No Abstract] [Full Text] [Related]
37. Destination therapy with ventricular assist devices.
Raman J; Jeevanadam V
Cardiology; 2004; 101(1-3):104-10. PubMed ID: 14988631
[TBL] [Abstract][Full Text] [Related]
38. [Surgical therapy of end-stage heart failure].
Christiansen S; Brose S; Autschbach R
Herz; 2003 Aug; 28(5):380-92. PubMed ID: 12928737
[TBL] [Abstract][Full Text] [Related]
39. One hundred days or more bridged on a ventricular assist device and effects on outcomes following heart transplantation.
Robertson JO; Lober C; Smedira NG; Navia JL; Sopko N; Gonzalez-Stawinski GV
Eur J Cardiothorac Surg; 2008 Aug; 34(2):295-300. PubMed ID: 18539472
[TBL] [Abstract][Full Text] [Related]
40. [Morbidity and mortality after heart transplanation].
Rebocho MJ; Aguiar C; Queiroz e Melo J
Rev Port Cardiol; 2001 Mar; 20 Suppl 3():67-74. PubMed ID: 11409076
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
